drugset / Trial / NCT01211873

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

NCT01211873

Phase 3 Completed 416 enrolled Guerbet
RandomizedParallel-groupQuadruple-blindDiagnostic

Summary

The purpose of this study is to look at the safety (what are the side effects)and efficacy (how well does it work) of Dotarem® when used in taking images of the brain / spine. The results will be compared to the results of MRI taken without Dotarem.

Timeline

Start
2010-09
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gadopentetate dimeglumine Diagnostic / imaging agent 0.1 unknown Intravenous
Subject Gadoterate meglumine Diagnostic / imaging agent 0.1 unknown Intravenous